Tag: Geng Ke

Capital markets lower entry threshold but ramp up accountability

Metis TechBio debuts on the HKEX on 13 May, raising HKD2.1 billion in the world’s first listing of an AI driven nano-delivery platform company

Cofoe Medical Technology lists on the HKEX main board becoming the first home medical equipment maker to achieve a dual listing

Health drinks producer Eastroc Beverage has debuted on the HKEX, raising HKD10.1 billion. HSF Kramer, DeHeng , Jia Yuan and O’Melveny advised on the listing

The A-List 2024-25: Legal leaders and influential lawyers in China's legal market

O’Melveny, Global Law Office, Linklaters and Haiwen & Partners have clinched roles in Chinese jewellery brand Laopu Gold’s listing on the HKEX

The A-List 2023-24: Legal leaders and influential lawyers in China's legal market

O’Melveny, Han Kun Law Offices, Maples Group, Latham & Watkins and Zhong Lun Law Firm advised on cancer drug developer Adlai Nortye’s Nasdaq debut

China’s AI unicorn Fourth Paradigm, after three previous attempts, has successfully listed on the HKEX raising HKD1.02 billion (USD130 million)

Luzhu Biotechnology debuted on the HKEX through chapter 18A, the first biotech company without any revenue or profits to be listed this year, raising USD43.45 million

O’Melveny advised China’s medical technology company, Acotec Scientific Holdings, on the voluntary partial offer for a majority stake of up to 65% by US-listed Boston Scientific Group

After thorough editorial survey and research, China Business Law Journal presents the elite lawyers in China’s legal market